Global biopharmaceutical company

  • Location: Raleigh, NC
  • Size: 82,985 SF
  • Type of Project: Manufacturing Facility


  • The Occupier Solutions Team was chosen to represent a biopharmaceutical company headquartered in France for site selection of an East Coast facility to serve the Americas. The company focused on developing a new generation of cancer immunotherapies based on gene-edited T-cells (UCART). 


  • Client sought North American presence with closest proximity to Europe.
  • The inventory of available space was extremely tight in 2019.


  • 2500 Sumner Boulevard in Raleigh was selected as a culmination of an extensive search – reflective of the current availability of suitable building inventory to support commercial manufacturing of UCART therapies.
  • The Occupier Solutions Team also assisted with connections and acquisitions in local and state economic development incentives.